Bafna Pharmaceuticals Limited (BOM:532989)

Market Cap	3.79B +113.6%
Revenue (ttm)	1.51B +3.3%
Net Income	111.00M +167.3%
EPS	4.69 +167.2%
Shares Out	n/a
PE Ratio	34.14
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,099
Open	155.75
Previous Close	156.50
Day's Range	155.75 - 164.30
52-Week Range	74.01 - 216.25
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 406
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532989

Financial Performance

In fiscal year 2026, Bafna Pharmaceuticals's revenue was 1.51 billion, an increase of 3.26% compared to the previous year's 1.46 billion. Earnings were 111.00 million, an increase of 167.30%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 20, 2026

Data Sources Report a data error